RxDoctor Payments Data

Conrad Benedetto, DO

MOHS-Micrographic Surgery · Drexel Hill, PANPI 1154718849

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 223 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 29.7% of the total. Reporting peaked in 2023 at $1,046 and has fallen 93.1% since, to $72 in 2025.

$4,054in general payments, 2019–2025

Across 223 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$369
  • Lilly USA, LLC$364
  • Bristol Myers Squibb$331
  • Novartis$308
  • E.r. Squibb & Sons, L.L.C.$280
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$4,039100%
  • Education$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,054 in reported general payments places this provider in the 70th percentile of 48 mohs-micrographic surgery providers in Pennsylvania.

See all mohs-micrographic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$675,141
Medicare patients
608
Services billed
1,762

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin269$1,174
Fluorouracil11$658
Clobetasol Propionate13$573
Doxycycline Hyclate85$490
Mupirocin48$428
Cefadroxil41$212
Ketoconazole14$193
Acetaminophen-CodeineAcetaminophen With Codeine13$34

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Drexel Hill

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →